Product information and disease descriptionPlace of product in therapyApproaches to treatment
Current treatment options and standard of care
77 evidence topics · 35 sources
First-line recurrent or metastatic HPV-negative head and neck squamous cell carcinoma, in combination with pembrolizumab
Product information and disease descriptionPlace of product in therapyApproaches to treatment
77 evidence topics · 35 sources